{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:25:37Z","timestamp":1747221937786,"version":"3.40.5"},"reference-count":8,"publisher":"Sociedade Brasileira de Pneumologia e Tisiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bras Pneumol."],"DOI":"10.36416\/1806-3756\/e20220426","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T16:14:06Z","timestamp":1668442446000},"page":"e20220426","source":"Crossref","is-referenced-by-count":2,"title":["Heterogeneity in rheumatoid arthritis-associated interstitial lung disease: time for splitting?"],"prefix":"10.36416","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0784-1331","authenticated-orcid":false,"given":"Leticia","family":"Kawano-Dourado1,2,3","sequence":"first","affiliation":[{"name":"1. HCOR Research Institute, Hospital do Cora\u00e7\u00e3o, S\u00e3o Paulo (SP) Brasil. 2. Divis\u00e3o de Pneumologia, Instituto do Cora\u00e7\u00e3o \u2013 InCor \u2013 Faculdade de Medici-na, Universidade de S\u00e3o Paulo, S\u00e3o Paulo (SP) Brasil. 3. MAGIC Evidence Ecosystem Foundation, Oslo, Norway."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3547-5674","authenticated-orcid":false,"given":"Karina","family":"Bonfiglioli4","sequence":"additional","affiliation":[{"name":"4. Divis\u00e3o de Reumatologia, Hospital das Cl\u00ednicas, Faculdade de Medicina, Uni-versidade de S\u00e3o Paulo, S\u00e3o Paulo (SP) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22288","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Raimundo K, Solomon JJ, Olson AL, Kong AM, Cole AL, Fischer A, et al. Rheumatoid Arthritis-Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs and Mortality [published correction appears in J Rheumatol. 2019 Feb;46(2):218]. J Rheumatol. 2019;46(4):360-369. https:\/\/doi.org\/10.3899\/jrheum.171315","DOI":"10.3899\/jrheum.171315"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Hyldgaard C, Hilberg O, Pedersen AB, Ulrichsen SP, L\u00f8kke A, Bendstrup E, et al. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann Rheum Dis. 2017;76(10):1700-1706. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211138","DOI":"10.1136\/annrheumdis-2017-211138"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"3. Juge PA, Lee JS, Ebstein E, Furukawa H, Dobrinskikh E, Gazal S, et al. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease. N Engl J Med. 2018;379(23):2209-2219. https:\/\/doi.org\/10.1056\/NEJMoa1801562","DOI":"10.1056\/NEJMoa1801562"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Kass DJ, Nouraie M, Glassberg MK, Ramreddy N, Fernandez K, Harlow L, et al. Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis [published correction appears in Arthritis Rheumatol. 2020 Apr;72(4):597]. Arthritis Rheumatol. 2020;72(3):409-419. https:\/\/doi.org\/10.1002\/art.41123","DOI":"10.1002\/art.41123"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Sparks JA, He X, Huang J, Fletcher EA, Zaccardelli A, Friedlander HM, et al. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study. Arthritis Rheumatol. 2019;71(9):1472-1482. https:\/\/doi.org\/10.1002\/art.40904","DOI":"10.1002\/art.40904"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"6. Rosseti-Severo C, Chomiski C, Borba do Valle M, Escuissato D, Paiva E, Storrer K. Assessment of risk factors in patients with rheumatoid arthritis-associated interstitial lung disease. J Bras Pneumol. 2022;48(6):e20220145.","DOI":"10.36416\/1806-3756\/e20220145"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Restrepo JF, del Rinc\u00f3n I, Battafarano DF, Haas RW, Doria M, Escalante A. Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis. Clin Rheumatol. 2015;34(9):1529-1536. https:\/\/doi.org\/10.1007\/s10067-015-3025-8","DOI":"10.1007\/s10067-015-3025-8"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"8. Esposito AJ, Sparks JA, Gill RR, Hatabu H, Schmidlin EJ, Hota PV, et al. Screening for preclinical parenchymal lung disease in rheumatoid arthritis. Rheumatology (Oxford). 2022;61(8):3234-3245. https:\/\/doi.org\/10.1093\/rheumatology\/keab891","DOI":"10.1093\/rheumatology\/keab891"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,3,12]],"date-time":"2023-03-12T01:13:48Z","timestamp":1678583628000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jornaldepneumologia.com.br\/details\/3770\/en-US\/heterogeneity-in-rheumatoid-arthritis-associated-interstitial-lung-disease--time-for-splitting-"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,14]]},"references-count":8,"URL":"https:\/\/doi.org\/10.36416\/1806-3756\/e20220426","relation":{},"ISSN":["1806-3756"],"issn-type":[{"type":"electronic","value":"1806-3756"}],"subject":[],"published":{"date-parts":[[2022,11,14]]}}}